Oral Session 3-10B CML: Clinical Study (2)

[OS3-10B-6] Outcome in adolescents and young adults with chronic myeloid leukemia treated with TKI

Yuriko Fujita¹, Tomonori Nakazato¹, Noriyoshi Iriyama², Michihide Tokuhira³, Maho Ishikawa⁴, Eriko Sato⁵, Tomoiku Takaku⁶, Keiji Sugimoto⁷, Hiroyuki Fujita⁸, Isao Fujioka⁶, Yuta Kimura³, Norio Komatsu⁶, Norio Asou⁴, Masahiro Kizaki³, Yoshihiro Hatta², Tatsuya Kawaguchi⁹ (1.Hematol, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 2.Department of Medicine, Nihon University School of Medicine, Tokyo, Japan, 3.Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan, 4.Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan, 5.Hematology, Juntendo University Nerima Hospital, Tokyo, Japan, 6.Hematology, Juntendo University School of Medicine, Tokyo, Japan, 7.Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan, 8.Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 9.Medical Technology, Kumamoto Health Science University, Kumamoto, Japan)